Answers are grounded in this paper and cite their sources.
Small molecule inhibitors of acetyl lysine–bromodomain interactions emerge as novel epigenetic tools with potential for therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Furdas et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: